Week 2 Flashcards

(37 cards)

1
Q

vi

A

the initial rate of the reaction at a certain substrate concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vmax

A

the maximal velocity a rxn can achieve at an infinite concentration of substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Km

A

substrate concentration at which the rxn rate is at half-max and is a measure of the substrate’s affinity for the enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Michaelis-Menten Equation

A

vi = Vmax[S]/(Km+[S])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

rate of rxns can be influenced by

A

temperature

H+ ion centration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

competitive inhibitor

A

binds in the active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

competitive inhibitor impact of Km

A

increases it - substrate concentration must increase to compete with inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

competitive inhibitor impact on Vmax

A

remains the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

do competitive inhibitors speed up or slow down the enzyme rxn

A

slow down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

the impact of a competitive inhibitor can be overcome by

A

increase in substrate concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

noncompetitive inhibitor

A

binds in an alternative location to the active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

impact of noncompetitive inhibitor on Vmax

A

Vmax decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

impact of noncompetitive inhibitor on Km

A

remains the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

allosteric effectors

A

bind to sites that are not the active sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

allosteric activators

A

positive effectors
enhance enzyme rxn
stabilize a conformation of the protein that increases substrate binding and rxn rate - Rstate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

allosteric inhibitors

A

negative effectors
inhibit enzyme rxn
stabilize a conformation of the protein that decreases binding of substrate and rxn rate

17
Q

phosphorylation by a kinase on…

A

the R groups of serine and tyrosine and sometimes threonine

18
Q

phosphorylations can…

A
  • change protein comformation and activity

- change protein charge

19
Q

kinases phosphorylate

A

serine and threonine

20
Q

tyrosine kinases phosphorylate

A

tyrosine residues

21
Q

protein phosphatases

A

hydrolyze the phosphoester bonds of phosphorseryl and phosphortyrosyl residues

22
Q

methylation is typical in

A

c or g nucleotides

23
Q

increased histone acetylation will result in

A

decreased histone:DNA interaction allowing for transcriptional accessibility

24
Q

types of covalent modification

A

phosphorylation
hydrolyzation
methylation
acetylation

25
pos delta G
rxn requires energy to take place
26
neg delta G
reaction is spontaneous
27
anabolic have pos or neg delta G
pos
28
catabolic have pos or neg delta G
neg
29
Phosphorylation of muscle glycogen phosphorylase is an example of
enzyme regulation through covalent modification
30
activation of chymotrypsinogen to chymotrypsin is an example of
enzyme activation by cleavage
31
The association of DNA and histones can be modified by histone acetylation. A decrease in histone acetylation will have what impact on the association of DNA and histones?
increase DNA: histone association
32
no change in Km with the addition of the drug but change in Vmax could indicate the drug is
a noncompetitive inhibitor
33
a drug that changes the Vmax without changing the Km has what impact on its target
reduces the catalytic activity of the enzyme
34
A new enzyme is discovered that increases in activity when it is phosphorylated on an exposed tyrosine residue. Phosphorylation of this amino acid is classified as...
covalent modification
35
change in Km with no change in vmax
competitive inhibitor
36
As levels of B increase, this will decrease the conversion of S3 to B. This describes what type of regulation in a biosynthetic pathway?
feedback inhibition
37
Children with cystinosis have growth delay and both renal and ocular issues due to accumulation of cysteine in cellular lysosomes. The defect involves a specific lysosomal membrane receptor that facilitates cysteine removal from the cell. An effective therapy has been administration of a drug with a similar structure to cysteine. This therapy reflects the general principle that competitive inhibitors typically resemble the structure of
substrates or ligands that bind the active site